Clinical Trial: Phase 1 Study on the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07595458) titled 'Phase 1 Study on the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults' on May 07.

Brief Summary: The goal of this clinical trial is to learn if a single dose of the study drug, JST-018, is safe and tolerable when administered by injection into the arm or thigh muscle of healthy men and women aged 18 to 55. The main questions it aims to answer are:

* Is a single administration of JST-018 safe?

* What is the concentration of the JST-018 in the blood over time?

* Do antibodies to JST-018 develop following a dose of JST-018? Researchers will compare JST-018 to Placebo to see if there are any differences in the s...